IGF-1 LR3 Dosage, Protocol, and Reconstitution Guide
IGF-1 LR3
IGF-1 LR3 is a long-acting analog of insulin-like growth factor 1 studied for its anabolic effects on muscle growth, recovery, and nutrient partitioning. Compared with standard IGF-1, its structural changes extend activity and reduce binding to IGF-binding proteins.
How It Works
IGF-1 Receptor Activation → Protein Synthesis ↑ → Recovery ↑ → Lean Mass Support
IGF-1 LR3 acts downstream of growth hormone signaling and supports anabolic activity in muscle and other tissues. It is commonly discussed for recovery, hypertrophy support, and nutrient utilization during training-focused protocols.
IGF-1 LR3 is a long-acting IGF-1 analog.
It works downstream of GH signaling rather than directly stimulating GH release.
It is commonly discussed for recovery, hypertrophy support, nutrient partitioning, and lean mass support.
Because it may influence blood glucose response, conservative dosing and careful monitoring are important.
IGF-1 LR3 Protocol
1 mg vial + 2.0 mL BAC Water → 1 unit = 5 mcg → Long-Acting IGF-1 Support
Standard Setup
Vial
1 mg
Water
2.0 mL bacteriostatic water
Concentration
0.5 mg/mL
Conversion
1 unit = 5 mcg
Weeks 1–2
Start Phase
Dose20 mcg
Units4 units
Volume0.04 mL
Weeks 3–4
Build Phase
Dose30 mcg
Units6 units
Volume0.06 mL
Weeks 5–8
Peak Phase
Dose40 mcg
Units8 units
Volume0.08 mL
Weeks 9–12
Advanced Extension
Dose50 mcg
Units10 units
Volume0.10 mL
Protocol Details
FrequencyOnce daily
TimingPost-workout or earlier in the day
Cycle Length4–8 weeks
Advanced ExtensionUp to 12 weeks
Simple structure
IGF-1 LR3 is usually approached with short, controlled cycles. Many protocols stay in the 20–50 mcg range to assess recovery, fullness, training output, and glucose response before considering higher ranges.
IGF-1 LR3 is usually approached with short, controlled cycles. Many protocols stay in the 20–50 mcg range to assess recovery, fullness, training output, and glucose response before considering higher ranges.
Advanced Protocol
Higher Range
Advanced
Dose50–100 mcg daily
Important:
Higher-dose use is generally reserved for more advanced protocols. Many users stay in the 20–50 mcg range for a more controlled approach.
Higher-dose use is generally reserved for more advanced protocols. Many users stay in the 20–50 mcg range for a more controlled approach.
How to Use IGF-1 LR3 (Timing & Injection)
Use StyleTraining-focused anabolic support
TimingPost-workout or earlier in the day
FrequencyOnce daily
RouteSubcutaneous injection is most common
Injection Notes
Subcutaneous injection is most common
Often used post-workout or earlier in the day
Abdomen, thigh, or upper arm are common sites
Rotate injection sites consistently
Timing Notes
Post-workout timing is common in training-focused protocols.
Earlier-in-the-day timing may be preferred to better monitor energy and glucose response.
Avoid stacking several growth-pathway compounds without a clear plan.
Track recovery, fullness, performance, and low-blood-sugar-like symptoms carefully.
Reconstitution & Dosing (1 mg Vial)
Vial1 mg
Water2.0 mL
Concentration500 mcg/mL
Conversion1 unit = 5 mcg
Dose Reference
4 units = 20 mcg
6 units = 30 mcg
8 units = 40 mcg
10 units = 50 mcg
20 units = 100 mcg
Reconstitution Steps
Draw 2.0 mL bacteriostatic water
Inject slowly down vial wall
Gently swirl, do not shake
Allow powder to fully dissolve
Label with the reconstitution date
Refrigerate immediately after mixing
Storage & Shelf Life
Storage & Shelf Life
Lyophilized (Unmixed Powder)
Short-term storage: keep refrigerated at 2–8°C
Long-term storage: freezing at −20°C is commonly preferred
Keep the vial sealed until ready to reconstitute
Protect from heat, sunlight, moisture, and repeated temperature swings
Avoid leaving lyophilized peptide at room temperature for extended periods
Do not repeatedly freeze and thaw the same vial
Estimated Unmixed Shelf Life
Refrigerated (2–8°C): commonly ~12–24 months when sealed and dry
Frozen (−20°C): commonly up to ~2–3 years when stored properly
Actual stability depends on supplier quality, handling, and storage conditions
Reconstituted (Mixed)
After mixing: refrigerate at 2–8°C
Use within ~30 days
Do not freeze after mixing
Discard if cloudy, discolored, or if particles appear
Best Practice
Lyophilized peptides are most stable when they stay cold, dry, sealed, and protected from light. Once mixed, the clock starts: keep refrigerated, avoid contamination, and use within the stated window.
Lyophilized peptides are most stable when they stay cold, dry, sealed, and protected from light. Once mixed, the clock starts: keep refrigerated, avoid contamination, and use within the stated window.
Cycle Length & Time Between Cycles
Training Phase → IGF-1 LR3 Cycle → Break → Reassess Growth + Recovery Response
Standard Cycle Structure
Cycle Length4–8 weeks
Advanced ExtensionUp to 12 weeks
Primary PhaseTraining-focused recovery and nutrient partitioning support
GoalLean mass support + recovery + training output
Time Between Cycles
Break4–8 weeks
Allows growth-pathway signaling to reset
Helps reduce diminishing returns from continuous exposure
Gives time to assess recovery, fullness, glucose response, and training changes
Why cycle?
IGF-1 LR3 is usually kept to shorter, intentional cycles because it is more potent than many beginner peptides and works directly on growth-related pathways. Cycling helps keep the protocol more controlled and easier to evaluate.
IGF-1 LR3 is usually kept to shorter, intentional cycles because it is more potent than many beginner peptides and works directly on growth-related pathways. Cycling helps keep the protocol more controlled and easier to evaluate.
When to Stop or Pause Early
Low-blood-sugar-like symptoms occur
Water retention becomes uncomfortable
Headaches or fatigue increase
Training recovery or body composition changes plateau
You are continuing without a clear training or recovery goal
Monitoring During Use
Recovery and soreness
Muscle fullness and training output
Body composition changes
Blood glucose response if sensitive
Water retention
Low-blood-sugar-like symptoms such as shakiness, sweating, or dizziness
Benefits
Supports muscle growth and repair
Improves nutrient partitioning
May enhance recovery speed
Can support lean body mass retention
Works downstream of GH signaling
Potential Side Effects
Injection site irritation
Possible headache
Water retention
Low blood sugar symptoms in sensitive users
Possible fatigue or dizziness if glucose response is affected
Stacking Strategies
IGF-1 Pathway Support → Recovery + Growth Layering → Avoid Overlap Without a Plan
Common Pairing Approaches
Growth Stack: IGF-1 LR3 + Ipamorelin
Recovery: IGF-1 LR3 + BPC-157
Advanced: IGF-1 LR3 + CJC-1295
What to Avoid
Stacking multiple IGF-related compounds without a clear plan
Combining with several GH secretagogues and growth-pathway peptides at once
Using high doses without monitoring glucose response
Running long continuous cycles without reassessing response
Simple rule
IGF-1 LR3 is already a strong growth-pathway compound. Stack carefully and avoid duplicating anabolic signaling unless there is a clear training, recovery, or body-composition reason.
IGF-1 LR3 is already a strong growth-pathway compound. Stack carefully and avoid duplicating anabolic signaling unless there is a clear training, recovery, or body-composition reason.
Important Notes
More potent than most beginner peptides
Often used in shorter cycles
Post-workout timing is common in training-focused protocols
Start low and assess response carefully
Blood glucose awareness is important
Best used with a clear training, nutrition, and recovery plan
Important Disclaimer
IGF-1 LR3 is not FDA-approved and is intended for research purposes only.
Comments
Post a Comment